Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

C-erbB-2 oncoprotein immunostaining in serous effusions

V Ascoli1, C C Scalzo, F Nardi

  • 1Dipartimento di Biopatologia Umana, Università La Sapienza, Rome, Italy.

Cytopathology : Official Journal of the British Society for Clinical Cytology
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Finding Neural Biomarkers for Motor Learning and Rehabilitation using an Explainable Graph Neural Network.

IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society·2025
Same author

Predictors of malignancy in high-risk indeterminate (TIR3B) cytopathology thyroid nodules.

Journal of endocrinological investigation·2020
Same author

GFPLAIN250m, a global high-resolution dataset of Earth's floodplains.

Scientific data·2019
Same author

What's new in mesothelioma.

Pathologica·2018
Same author

Evaluation of the Italian cytological subclassification of thyroid indeterminate nodules into TIR-3A and TIR-3B: a retrospective study of 290 cases with histological correlation from a single institution.

Journal of endocrinological investigation·2017
Same author

Zenker diverticulum in the right side of the neck resembling a thyroid mass at ultrasound.

Journal of biological regulators and homeostatic agents·2017
Same journal

Diagnostic Utility of the Milan System for Reporting Salivary Gland Cytopathology With Cytohistological Correlation.

Cytopathology : official journal of the British Society for Clinical Cytology·2026
Same journal

Genotypes and Risk Factors for Anal Cytological Abnormalities in People Living With HIV and High-Risk Human Papillomavirus: The GAIA 2 Study Cytological Abnormalities in People Living With HIV and High-Risk Human Papillomavirus.

Cytopathology : official journal of the British Society for Clinical Cytology·2026
Same journal

Architectural Subtyping of Three-Dimensional Cell Groups in Bethesda III Thyroid Cytology: Distinguishing Spherules From Their Mimickers.

Cytopathology : official journal of the British Society for Clinical Cytology·2026
Same journal

Cervical Cytokine Profile in High-Grade Squamous Intraepithelial Lesions.

Cytopathology : official journal of the British Society for Clinical Cytology·2026
Same journal

COVID-19's Shadow: The Effect of COVID-19 on Cytopathology Specimens Received at an Academic Laboratory in Central South Africa.

Cytopathology : official journal of the British Society for Clinical Cytology·2026
Same journal

Psammoma Bodies in Cervical Liquid-Based Cytology of a Kyleena User.

Cytopathology : official journal of the British Society for Clinical Cytology·2026
See all related articles

The c-erbB-2 oncoprotein is found in 51% of malignant effusions, particularly adenocarcinomas. This immunocytochemical marker aids in distinguishing cancers from mesotheliomas and offers prognostic insights.

Area of Science:

  • Oncology
  • Pathology
  • Biomarker Discovery

Background:

  • The c-erbB-2 (human epidermal growth factor receptor 2) oncoprotein is implicated in various carcinomas, often correlating with advanced malignancy.
  • Accurate diagnosis and prognosis in malignant effusions are critical for patient management.

Purpose of the Study:

  • To evaluate the utility of immunocytochemical detection of the c-erbB-2 oncoprotein in cytological effusions.
  • To assess its role in differentiating metastatic adenocarcinomas from mesotheliomas and its potential as a prognostic indicator.

Main Methods:

  • Immunocytochemistry was performed on 58 malignant and 16 benign effusions using the NCL-B11 monoclonal antibody against the c-erbB-2 oncoprotein.
  • Both alcohol-fixed smears and cell blocks from formalin-fixed specimens were analyzed.

Related Experiment Videos

Main Results:

  • Positive c-erbB-2 expression was observed in 51% (30/58) of malignant effusions, exclusively in metastatic adenocarcinomas.
  • Breast and ovarian adenocarcinomas exhibited the highest positivity rates.
  • Mesotheliomas and non-neoplastic effusions were consistently negative for c-erbB-2.
  • Alcohol-fixed smears showed stronger immunoreactivity than formalin-fixed paraffin-embedded cell blocks.

Conclusions:

  • C-erbB-2 oncoprotein detection is feasible and valuable in standard cytological smears.
  • Immunocytochemical analysis of c-erbB-2 can aid in differentiating adenocarcinomas from mesotheliomas.
  • This method may serve as a prognostic indicator, potentially replacing tissue immunohistochemistry in certain cases.